N-Acetyl-5-hydroxytryptamine | 			
N-acetylserotonin | 
				
1210-83-9 | 			
N-2-(5-Hydroxy-1H-indol-3-yl)ethylacetamide | 
				
acetylserotonin | 			
Normelatonin | 
				
N-ACETYL SEROTONIN | 			
O-Demethylmelatonin | 
				
5-Hydroxy-N-acetyltryptamine | 			
UNII-P4TO3C82WV | 
				
Acetyl-5-hydroxy-tryptamine | 			
5-Hydroxymelatonin | 
				
N-(2-(5-Hydroxy-1H-indol-3-yl)ethyl)acetamide | 			
3-(2-Acetamidoethyl)-5-hydroxyindole | 
				
P4TO3C82WV | 			
Acetamide, N-2-(5-hydroxy-1H-indol-3-yl)ethyl- | 
				
CHEMBL33103 | 			
CHEBI:17697 | 
				
MFCD00005656 | 			
N-Acetylserotonin; Normelatonin; O-Demethylmelatonin | 
				
2,2,2-trideuterio-N-1,1,2,2-tetradeuterio-2-(5-hydroxy-1H-indol-3-yl)ethylacetamide | 			
Desmethylmelatonin | 
				
N-acetyl-serotonin | 			
Serotonin,N-acetyl | 
				
N-acetyl serotonine | 			
EINECS 214-916-5 | 
				
Serotonin, N-acetyl- | 			
Spectrum_000369 | 
				
Spectrum3_001871 | 			
Spectrum4_001268 | 
				
Spectrum5_000975 | 			
Lopac-A-1824 | 
				
ACMC-1BO7I | 			
Acetamide, N-2-(5-hydroxyindol-3-yl)ethyl- | 
				
N-Acetyl-5-hydroxytryptamin | 			
Lopac0_000044 | 
				
BSPBio_003342 | 			
KBioGR_001856 | 
				
KBioSS_000849 | 			
N-Acetyltryptamine,5-Hydroxy | 
				
MLS000859911 | 			
DivK1c_000668 | 
				
SCHEMBL422165 | 			
SPECTRUM1500700 | 
				
GTPL5451 | 			
N-Acetylserotonin; Normelatonin | 
				
BDBM29612 | 			
HMS502B10 | 
				
KBio1_000668 | 			
KBio2_000849 | 
				
KBio2_003417 | 			
KBio2_005985 | 
				
KBio3_002844 | 			
N-Acetylserotonin|||Normelatonin | 
				
ZINC66104 | 			
DTXSID00153106 | 
				
Tryptamine, N-acetyl-5-hydroxy- | 			
NINDS_000668 | 
				
HMS2235E22 | 			
HMS3260I09 | 
				
HMS3372M05 | 			
N-Acetyl-5-hydroxytryptamine, 99% | 
				
Tox21_500044 | 			
7506AH | 
				
PDSP1_001650 | 			
PDSP1_001789 | 
				
PDSP1_001790 | 			
PDSP1_001827 | 
				
PDSP2_001634 | 			
PDSP2_001772 | 
				
PDSP2_001773 | 			
PDSP2_001810 | 
				
s2985 | 			
AKOS004120085 | 
				
CCG-204140 | 			
DB04275 | 
				
LP00044 | 			
MCULE-4114943625 | 
				
SDCCGSBI-0050033.P003 | 			
VZ33043 | 
				
IDI1_000668 | 			
NCGC00015039-01 | 
				
NCGC00015039-02 | 			
NCGC00015039-03 | 
				
NCGC00015039-04 | 			
NCGC00015039-05 | 
				
NCGC00015039-06 | 			
NCGC00015039-07 | 
				
NCGC00015039-09 | 			
NCGC00093558-01 | 
				
NCGC00093558-02 | 			
NCGC00093558-03 | 
				
NCGC00093558-04 | 			
NCGC00093558-05 | 
				
NCGC00260729-01 | 			
AS-59415 | 
				
SMR000326772 | 			
ST092857 | 
				
DB-007732 | 			
HY-107854 | 
				
A1277 | 			
CS-0030736 | 
				
EU-0100044 | 			
FT-0629855 | 
				
N-2-(5-hydroxyindol-3-yl)ethylacetamide | 			
A 1824 | 
				
A-1300 | 			
C00978 | 
				
T70144 | 			
A804654 | 
				
L000433 | 			
N-(2-(5-hydroxy-1H-indol-3-yl)ethyl) acetamide | 
				
SR-01000075660 | 			
Acetamide,N-2-(5-hydroxy-1H-indol-3-yl)ethyl- | 
				
N-2-(5-Hydroxy-1H-indol-3-yl)ethylacetamide # | 			
N-2-(5-oxidanyl-1H-indol-3-yl)ethylethanamide | 
				
Q4847704 | 			
SR-01000075660-1 | 
				
BRD-K26140483-001-01-3 | 			
N-Acetyl-5-hydroxytryptamine, >=99% (TLC), powder | 
				
Q27216205 | 			
7D6F82BE-C205-424F-9F26-65CE227610C0 |